Potential of antiviral peptide-based SARS-CoV-2 inactivators to combat COVID-19

The appearance of new variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the lack of effective antiviral therapeutics for coronavirus disease 2019 (COVID-19), a highly infectious disease caused by the virus, demands the search for alternative therapies. Most antiviral drugs...

Descripción completa

Detalles Bibliográficos
Autores principales: Gurung, Arun Bahadur, Ali, Mohammad Ajmal, Lee, Joongku, El-Zaidy, Mohamed, Aljowaie, Reem M., Almutairi, Saeedah M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165783/
https://www.ncbi.nlm.nih.gov/pubmed/35657783
http://dx.doi.org/10.1371/journal.pone.0268919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165783/
https://www.ncbi.nlm.nih.gov/pubmed/35657783
http://dx.doi.org/10.1371/journal.pone.0268919

Ejemplares similares